Dose-Dense Biweekly Doxorubicin/Docetaxel Versus Sequential Neoadjuvant Chemotherapy with Doxorubicin/Cyclophosphamide/Docetaxel in Operable Breast Cancer: Second Interim Analysis

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

Bernard Fisher, John Bryant, Norman Wolmark et al. · Journal of Clinical Oncology · 1998 · 2.2K citations

Medicine, Oncology, Surgery +17

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.

Bernard Fisher, A Brown, E.P. Mamounas et al. · Journal of Clinical Oncology · 1997 · 1.8K citations

Medicine, Oncology, Surgery +17

Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

Henry M. Kuerer, Lisa A. Newman, Terry L. Smith et al. · Journal of Clinical Oncology · 1999 · 1.3K citations

Medicine, Oncology, Surgery +17

Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902

Jos A. van der Hage, Cornelis J.�H. van de Velde, Jean‐Pierre Julien et al. · Journal of Clinical Oncology · 2001 · 1.1K citations

Medicine, Oncology, Breast Oncology +14

Neoadjuvant Chemotherapy in Breast Cancer: Significantly Enhanced Response With Docetaxel

Ian C. P. Smith · Journal of Clinical Oncology · 2002 · 716 citations

Medicine, Oncology, Pharmacology +15